Overexpression of nuclear β-catenin in rectal adenocarcinoma is associated with radioresistance

World Journal of Gastroenterology

Volumn 19, Issue 40, 2013, Pages 6876-6882

  Wang, Lin ^a   Zhang, Xiao Mei ^a   Li, Zhen ^a   Liu, Xi Jun ^b   Chai, Jie ^b   Zhang, Guang Yong ^a   Cheng, Yu Feng ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Colorectal cancer; Preoperative radiotherapy; Radioresistance; Rectal cancer; catenin

Indexed keywords

BETA CATENIN;

ADULT; AGED; ARTICLE; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; PREDICTIVE VALUE; RADIOSENSITIVITY; RECTUM CARCINOMA; RETROSPECTIVE STUDY; TUMOR BIOPSY;

COLORECTAL CANCER; PREOPERATIVE RADIOTHERAPY; RADIORESISTANCE; RECTAL CANCER; Β-CATENIN;

ADENOCARCINOMA; ADULT; AGED; BETA CATENIN; CELL DIFFERENTIATION; CELL NUCLEUS; CHI-SQUARE DISTRIBUTION; DOSE FRACTIONATION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; NEOPLASM GRADING; ODDS RATIO; RADIATION TOLERANCE; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84886995708     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i40.6876     Document Type: Article

References (23)

1. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-1740 [PMID: 15496622 DOI: 10.1056/NEJMoa040694]
2. Lim SB, Yu CS, Hong YS, Kim TW, Kim JH, Kim JC. Longterm outcomes in patients with locally advanced rectal cancer treated with preoperative chemoradiation followed by curative surgical resection. J Surg Oncol 2012; 106: 659-666 [PMID: 22674581 DOI: 10.1002/jso.23181]
3. Pacelli F, Sanchez AM, Covino M, Tortorelli AP, Bossola M, Valentini V, Gambacorta MA, Doglietto GB. Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases. Am Surg 2013; 79: 151-161 [PMID: 23336654]
4. Bujko K, Richter P, Smith FM, Polkowski W, Szczepkowski M, Rutkowski A, Dziki A, Pietrzak L, Kołodziejczyk M, Kuśnierz J, Gach T, Kulig J, Nawrocki G, Radziszewski J, Wierzbicki R, Kowalska T, Meissner W, Radkowski A, Paprota K, Polkowski M, Rychter A. Preoperative radiotherapy and local excision of rectal cancer with immediate radical re-operation for poor responders: a prospective multicentre study. Radiother Oncol 2013; 106: 198-205 [PMID: 23333016 DOI: 10.1016/j.radonc.2012.12.005]
5. Moussata D, Amara S, Siddeek B, Decaussin M, Hehlgans S, Paul-Bellon R, Mornex F, Gerard JP, Romestaing P, Rödel F, Flourie B, Benahmed M, Mauduit C. XIAP as a radioresistance factor and prognostic marker for radiotherapy in human rectal adenocarcinoma. Am J Pathol 2012; 181: 1271-1278 [PMID: 22867709 DOI: 10.1016/j.ajpath.2012.06.029]
6. Qiu J, Yang G, Shen Z, Xie Y, Wang L. hPEBP4 as a predic-tive marker for the pathological response of rectal cancer to preoperative radiotherapy. Int J Colorectal Dis 2013; 28: 241-246 [PMID: 22801881 DOI: 10.1007/s00384-012-1534-3]
7. Kuremsky JG, Tepper JE, McLeod HL. Biomarkers for response to neoadjuvant chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys 2009; 74: 673-688 [PMID: 19480968 DOI: 10.1016/j.ijrobp.2009.03.003]
8. Harris TJ, Peifer M. Decisions, decisions: beta-catenin chooses between adhesion and transcription. Trends Cell Biol 2005; 15: 234-237 [PMID: 15866026]
9. van Es JH, Barker N, Clevers H. You Wnt some, you lose some: oncogenes in the Wnt signaling pathway. Curr Opin Genet Dev 2003; 13: 28-33 [PMID: 12573432]
10. Woodward WA, Chen MS, Behbod F, Alfaro MP, Buchholz TA, Rosen JM. WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci USA 2007; 104: 618-623 [PMID: 17202265 DOI: 10.1073/ pnas.0606599104]
11. Chen MS, Woodward WA, Behbod F, Peddibhotla S, Alfaro MP, Buchholz TA, Rosen JM. Wnt/beta-catenin mediates radiation resistance of Sca1+ progenitors in an immortalized mammary gland cell line. J Cell Sci 2007; 120: 468-477 [PMID: 17227796 DOI: 10.1242/jcs.03348]
12. Horst D, Reu S, Kriegl L, Engel J, Kirchner T, Jung A. The intratumoral distribution of nuclear beta-catenin is a prognostic marker in colon cancer. Cancer 2009; 115: 2063-2070 [PMID: 19298008 DOI: 10.1002/cncr.24254]
13. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997; 12: 19-23 [PMID: 9112145]
14. Perez RO. Predicting response to neoadjuvant treatment for rectal cancer: a step toward individualized medicine. Dis Colon Rectum 2011; 54: 1057-1058 [PMID: 21825883 DOI: 10.1097/DCR.0b013e31822182ce]
15. Wang Y, Liu L, Zhou D. Inhibition of p38 MAPK attenuates ionizing radiation-induced hematopoietic cell senescence and residual bone marrow injury. Radiat Res 2011; 176: 743-752 [PMID: 22014293]
16. Ho SY, Wu WJ, Chiu HW, Chen YA, Ho YS, Guo HR, Wang YJ. Arsenic trioxide and radiation enhance apoptotic effects in HL-60 cells through increased ROS generation and regulation of JNK and p38 MAPK signaling pathways. Chem Biol Interact 2011; 193: 162-171 [PMID: 21741957 DOI: 10.1016/ j.cbi.2011.06.007]
17. Shioya M, Takahashi T, Ishikawa H, Sakurai H, Ebara T, Suzuki Y, Saitoh J, Ohno T, Asao T, Kuwano H, Nakano T. Expression of hypoxia-inducible factor 1α predicts clinical outcome after preoperative hyperthermo-chemoradiotherapy for locally advanced rectal cancer. J Radiat Res 2011; 52: 821-827 [PMID: 22104271]
18. Kim K, Chie EK, Wu HG, Kim SG, Lee SH, Kang GH, Hyun CL, Ha SW. High survivin expression as a predictor of poor response to preoperative chemoradiotherapy in locally advanced rectal cancer. Int J Colorectal Dis 2011; 26: 1019-1023 [PMID: 21424389 DOI: 10.1007/s00384-011-1180-1]
19. Shinto E, Hashiguchi Y, Ueno H, Kobayashi H, Ishiguro M, Mochizuki H, Yamamoto J, Hase K. Pretreatment CD133 and cyclooxygenase-2 expression as the predictive markers of the pathological effect of chemoradiotherapy in rectal cancer patients. Dis Colon Rectum 2011; 54: 1098-1106 [PMID: 21825889 DOI: 10.1097/DCR.0b013e3182218155]
20. Kim Y, Kim KH, Lee J, Lee YA, Kim M, Lee SJ, Park K, Yang H, Jin J, Joo KM, Lee J, Nam DH. Wnt activation is implicated in glioblastoma radioresistance. Lab Invest 2012; 92: 466-473 [PMID: 22083670 DOI: 10.1038/labinvest.2011.161]
21. Watson RL, Spalding AC, Zielske SP, Morgan M, Kim AC, Bommer GT, Eldar-Finkelman H, Giordano T, Fearon ER, Hammer GD, Lawrence TS, Ben-Josef E. GSK3beta and betacatenin modulate radiation cytotoxicity in pancreatic cancer. Neoplasia 2010; 12: 357-365 [PMID: 20454507]
22. Zhang B, Ougolkov A, Yamashita K, Takahashi Y, Mai M, Minamoto T. beta-Catenin and ras oncogenes detect most human colorectal cancer. Clin Cancer Res 2003; 9: 3073-3079 [PMID: 12912959]
23. Baldus SE, Mönig SP, Huxel S, Landsberg S, Hanisch FG, Engelmann K, Schneider PM, Thiele J, Hölscher AH, Dienes HP. MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis. Clin Cancer Res 2004; 10: 2790-2796 [PMID: 15102686 DOI: 10.1158/1078-0432.CCR-03-0163]